Senior leaders from UnitedHealth (UNH) Group will be meeting with investors and analysts between September 8, 2025 and September 10, 2025, during which the company intends to reaffirm its adjusted 2025 earnings per share expectations previously disclosed by the company on July 29, 2025. This outlook incorporates closing the acquisition of Amedisys in August 2025, which is expected to be modestly dilutive to adjusted earnings per share due to financing costs and the integration related investments. The meetings may also include discussion of the company’s strategy, market positions and recent results, as previously disclosed. UnitedHealth previously forecast FY25 adjusted EPS of at least $16.00 and revenue $445.5B-$448B. Analysts currently expect EPS of $16.24 and revenue of $448.2B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UNH vs. CVS: Which Healthcare Stock Has More Upside, According to Wall Street?
- Two Wall Street Analysts Reaffirm Confidence in UnitedHealth Stock (UNH)
- Why UnitedHealth Stock (UNH) Got a Price Target Bump from Barclays
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- UnitedHealth Stock (UNH) Down 37% YTD, Technical Indicators Suggest a “Buy”